ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,643, issued on March 3, was assigned to Ramot at Tel-Aviv University Ltd. (Tel-Aviv, Israel).

"Polymeric nanovaccines and uses thereof" was invented by Ronit Satchi-Fainaro (Tel-Aviv, Israel), Helena Florindo (Tel-Aviv, Israel), Joao Conniot (Tel-Aviv, Israel) and Anna Scomparin (Tel-Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A polymeric nanoparticle is disclosed which comprises: (i) at least one disease-associated antigen which is capable of producing a T-cell response, wherein the disease-associated antigen is encapsulated in the nanoparticle; (ii) at least one adjuvant; and (iii) a dendritic cell targeting moiety which is attache...